Monodisperse core-shell structured up-conversion Yb(OH)CO₃@YbPO₄:Er³+ hollow spheres as drug carriers.
about
Upconversion nanoparticles: design, nanochemistry, and applications in theranosticsFacile fabrication and photoluminescence properties of rare-earth-doped Gd₂O₃ hollow spheres via a sacrificial template method.Upconversion nanoparticles for photodynamic therapy and other cancer therapeuticsUpconversion nanophosphors for small-animal imaging.Defect-related luminescent materials: synthesis, emission properties and applications.Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications.Lanthanide-doped hollow nanomaterials as theranostic agents.Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery.Hierarchically Structured Nanomaterials for Electrochemical Energy Conversion.Facile synthesis of water-soluble luminescent mesoporous Tb(OH)3@SiO2 core-shell nanospheresRecent advances in lanthanide-doped upconversion nanomaterials: synthesis, nanostructures and surface modification.Nanoparticle conversion chemistry: Kirkendall effect, galvanic exchange, and anion exchange.Synthesis and luminescent properties of uniform monodisperse LuPO4:Eu3+/Tb3+ hollow microspheres.A Hollow NaGdF4 /AFn Nanosystem Based on "Relay Race" Release for Therapy.Controllable synthesis and tunable luminescence properties of Y2(WO4)3:Ln3+ (Ln = Eu, Yb/Er, Yb/Tm and Yb/Ho) 3D hierarchical architectures.A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.Large-scale fabrication of porous YBO3 hollow microspheres with tunable photoluminescence.Upconverting nanoparticles for pre-clinical diffuse optical imaging, microscopy and sensing: Current trends and future challengesDesigned preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapy
P2860
Q26830008-83E05463-AC6C-4291-9DCB-CA794DC9C5F6Q34784170-1CFAFC86-CC44-4136-91B5-E383B8F7FBBCQ36818538-EDA5B282-1389-4F1F-BDE4-B3EE005BB491Q37947053-9E263DA1-2885-4DEC-A5C1-A777EDC7BC6CQ38047286-C2383A81-1F4F-43CA-AE50-A4388917D5ECQ38118224-EA114D49-F86A-48D7-8125-583834E9096BQ38162427-0F9815E0-D061-44B6-8F51-771571E95AF6Q38225630-DD5C685A-7C47-4A87-A161-1A0C6EA2C5F5Q38628260-B1CEB2A3-378E-45BA-8914-FCF5F32FC58EQ40897190-C8C19CB2-35FD-4BA1-8AEE-5B27412167C2Q44560391-87358A71-DBCF-44A8-9FC1-7C3231C18E28Q44874726-DCEEF17B-FB1A-4465-A21C-67FF1F1CF3EDQ47195531-36132CA2-8CE5-4472-AEA8-963300C3FD07Q48180722-1619B8EA-6883-446D-B59A-3B0E574174DFQ50249868-1B5254EF-0076-4779-8238-F1E71BF37963Q50942494-07CFA4DA-AE4B-433B-AAEE-DB5697DC0486Q55177696-04E397FC-AAEB-481D-840C-CBF36B346D46Q57343374-DF4EDDE5-6540-44EA-8230-C6C4A168C586Q57376931-FE80D3EE-C00E-46A4-86D3-C5281CF8E7EF
P2860
Monodisperse core-shell structured up-conversion Yb(OH)CO₃@YbPO₄:Er³+ hollow spheres as drug carriers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@ast
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@en
type
label
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@ast
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@en
prefLabel
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@ast
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@en
P2093
P1433
P1476
Monodisperse core-shell struct ...... llow spheres as drug carriers.
@en
P2093
Chunxia Li
Ping'an Ma
Shanshan Huang
Xuefeng Zhai
Zhiyao Hou
P304
P356
10.1016/J.BIOMATERIALS.2011.02.026
P577
2011-03-23T00:00:00Z